CN101843857B - Chinese medicament for treating diabetic eyeground pathological changes - Google Patents

Chinese medicament for treating diabetic eyeground pathological changes Download PDF

Info

Publication number
CN101843857B
CN101843857B CN2009102354902A CN200910235490A CN101843857B CN 101843857 B CN101843857 B CN 101843857B CN 2009102354902 A CN2009102354902 A CN 2009102354902A CN 200910235490 A CN200910235490 A CN 200910235490A CN 101843857 B CN101843857 B CN 101843857B
Authority
CN
China
Prior art keywords
parts
chinese
chinese medicine
chinese medicament
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102354902A
Other languages
Chinese (zh)
Other versions
CN101843857A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sky, Jiangsu and pharmaceutical Co. Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102354902A priority Critical patent/CN101843857B/en
Publication of CN101843857A publication Critical patent/CN101843857A/en
Application granted granted Critical
Publication of CN101843857B publication Critical patent/CN101843857B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating diabetic eyeground pathological changes, and belongs to the field of Chinese medicaments for treating ophthalmology diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: mulberry leaf, lucid ganoderma, root of rehmannia, Chinese angelica, radix pseudo-ginseng, chrysanthemum, lalang grass rhizome and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and clearing liver and improving vision, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of diabetic retinopathy
Technical field
The invention belongs to the field of Chinese medicines of treatment ophthalmic diseases.
Background technology
The existing Chinese medicine that is intended to treat diabetic retinopathy, exist some obviously not enough: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, western medicine and medical practitioners is dry and astringent to blurred vision, the eyes that the diabetes-alleviating retinopathy forms in addition, not effective especially means and channel, so that a large amount of diabetic retinopathy conditions of patients constantly develop blind at last disabling.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of diabetic retinopathy, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of diabetic retinopathy adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Folium Mori 4-30 part Ganoderma 2-12 part Radix Rehmanniae 4-30 part
Radix Angelicae Sinensis 4-30 part Radix Notoginseng 3-20 part Flos Chrysanthemi 4-30 part
Rhizoma Imperatae 4-30 part
The Chinese medicine of this treatment diabetic retinopathy is made by following method:
(1) by above-mentioned weight ratio, Folium Mori, the Radix Rehmanniae, Radix Angelicae Sinensis, Flos Chrysanthemi, Rhizoma Imperatae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood in the side, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; Be aided with the Flos Chrysanthemi supplementing QI and nourishing YIN, dispelling pathogenic wind for improving eyesight; The Folium Mori dispelling wind and heat pathogens, liver heat removing and eyesight improving; The Rhizoma Imperatae cooling blood for hemostasis is in case eyes are hemorrhage.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, supplementing QI and nourishing YIN, and blood circulation promoting and blood stasis dispelling, the merit of liver heat removing and eyesight improving, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Folium Mori 80 kairine sesames 40 gram Radix Rehmanniae 80 grams
Radix Angelicae Sinensis 80 gram Radix Notoginseng 60 gram Flos Chrysanthemis 80 grams
Rhizoma Imperatae 80 grams
Weight in accordance with regulations, with conventional water extraction process Folium Mori, the Radix Rehmanniae, Radix Angelicae Sinensis, Flos Chrysanthemi, Rhizoma Imperatae are extracted, make extractum fine powder 120 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 785 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Folium Mori 160 kairine sesames 70 gram Radix Rehmanniae 160 grams
Radix Angelicae Sinensis 160 gram Radix Notoginseng 100 gram Flos Chrysanthemis 160 grams
Rhizoma Imperatae 160 grams
By above-mentioned same method, make 1464 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Folium Mori 300 kairine sesames 120 gram Radix Rehmanniae 300 grams
Radix Angelicae Sinensis 300 gram Radix Notoginseng 200 gram Flos Chrysanthemis 300 grams
Rhizoma Imperatae 300 grams
By above-mentioned same method, make 3071 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts in 3 parts of Radix Rehmanniae of 6 portions of Ganodermas of Folium Mori
6 parts of 5 parts of Flos Chrysanthemis of 6 portions of Radix Notoginseng of Radix Angelicae Sinensis
6 parts of Rhizoma Imperataes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts in 8 parts of Radix Rehmanniae of 20 portions of Ganodermas of Folium Mori
20 parts of 15 parts of Flos Chrysanthemis of 20 portions of Radix Notoginseng of Radix Angelicae Sinensis
20 parts of Rhizoma Imperataes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic ophthalmopathy (retinopathy), through 9 routine clinical observations.Selecting the tcm diagnosis diabetic retinopathy is standard: diabetics is had a dizzy spell, and gum is too much; Binocular dryness, eye socket pain; Visual deterioration, blurred vision; That retina occurs is hemorrhage, edema, ooze out.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 4 examples do not have other serious disease, and the age is 43 years old-72 years old, 61.6 years old mean age.
Efficacy determination:
1, produce effects: gum is normal, eyes Clear and Bright; Binocular dryness disappears, and eyes are comfortable; Blurred vision is alleviated, and vision improves more than 0.1; White macula, macula lutea, the minimizing of blood stain quantity appear in the optical fundus, and area dwindles.
2, effective: the dry and astringent disappearance of eyes, blurred vision is alleviated.
3, invalid: the disease no change.
During clinical experiment, except that the antidiabetic drug that diabetics is necessary is taken (medicine is constant, amount is constant) as usual, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.9 philtrums of clinical experiment, produce effects 4 people, effective 4 people, invalid 1 people, total effective rate 88.8%.

Claims (1)

1. a Chinese medicine for the treatment of diabetic retinopathy adopts the raw material of Chinese medicine preparation, by weight prescription is:
4-30 parts in 2-12 parts of Radix Rehmanniae of 4-30 parts of Ganodermas of Folium Mori
4-30 parts of 3-20 parts of Flos Chrysanthemis of 4-30 parts of Radix Notoginseng of Radix Angelicae Sinensis
4-30 parts of Rhizoma Imperataes
The Chinese medicine of this treatment diabetic retinopathy is made by following method:
(1) by above-mentioned weight ratio, Folium Mori, the Radix Rehmanniae, Radix Angelicae Sinensis, Flos Chrysanthemi, Rhizoma Imperatae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine electuary, granule, powder, capsule, watered pill, Tabules.
CN2009102354902A 2009-10-16 2009-10-16 Chinese medicament for treating diabetic eyeground pathological changes Expired - Fee Related CN101843857B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102354902A CN101843857B (en) 2009-10-16 2009-10-16 Chinese medicament for treating diabetic eyeground pathological changes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102354902A CN101843857B (en) 2009-10-16 2009-10-16 Chinese medicament for treating diabetic eyeground pathological changes

Publications (2)

Publication Number Publication Date
CN101843857A CN101843857A (en) 2010-09-29
CN101843857B true CN101843857B (en) 2011-07-27

Family

ID=42768796

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102354902A Expired - Fee Related CN101843857B (en) 2009-10-16 2009-10-16 Chinese medicament for treating diabetic eyeground pathological changes

Country Status (1)

Country Link
CN (1) CN101843857B (en)

Also Published As

Publication number Publication date
CN101843857A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843837B (en) Chinese medicament for treating diabetic oculopathy
CN101884693B (en) Traditional Chinese medicine for treating diabetic eye diseases
CN102379967A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101843786A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101843836B (en) Chinese medicament for treating diabetic oculopathy
CN101843857B (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101843834B (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101966258A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102389484A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101897809A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101843770A (en) Chinese medicament for treating diabetic oculopathy
CN101843772A (en) Chinese medicament for treating diabetic oculopathy
CN101843788A (en) Chinese medicament for treating diabetic oculopathy
CN101843727A (en) Chinese medicament for treating diabetic oculopathy
CN102018757A (en) Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes
CN101972343A (en) Traditional Chinese medicine for treating diabetic oculopathy
CN101940659A (en) Traditional Chinese medicine for treating diabetic eye disease
CN101953939A (en) Chinese medicament for treating diabetic eye diseases
CN101843774A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101843785A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101843752A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN102389495A (en) Traditional Chinese medicine for curing diabetic retinopathy
CN102114121A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101843725A (en) Chinese medicament for treating diabetic oculopathy
CN101953938A (en) Traditional Chinese medicine for treating diabetic retinopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANGSU TIANHE PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141202

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Zhao Yunde

Inventor after: Xu Jiao

Inventor after: Zhuang Weidong

Inventor before: Liu Xinzhuang

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU XINZHUANG TO: ZHAO YUNDE XU JIAO ZHUANG WEIDONG

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 225200 YANGZHOU, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20141202

Address after: 225200, Sanjiang Road, Yangzhou District, Jiangdu District, Jiangsu, 1

Patentee after: Sky, Jiangsu and pharmaceutical Co. Ltd

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110727

Termination date: 20151016

EXPY Termination of patent right or utility model